Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Tickers UNCY
Exposures Product Safety
Kaplan Fox &amp; Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Tickers UNCY
Exposures Product Safety
AINewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
Tickers LTRN
Exposures Artificial Intelligence Product Safety
FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls
Via Benzinga
Tickers ARGX
Exposures Product Safety
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
Via Benzinga
Tickers INMB
Exposures Product Safety
FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval
Via Benzinga
Tickers UNCY
Exposures Product Safety
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Via Investor Brand Network
Tickers CLNN SAP
Exposures Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Added to Russell 3000 and Russell 2000 Indexes
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
Via Benzinga
Tickers ACLX AUTL BMY CABA
Exposures Product Safety
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
Via Stocktwits
Tickers AVUS COIN EAOR MRNA
Exposures Product Safety
Larry Page Rejected Steve Jobs' 'Do One Thing' Well Advice, Built Everything Instead: Palo Alto CEO Nikesh Arora Recalls Google's 'Product-Obsessed' Roots
Via Benzinga
Topics Product Recall
Tickers AAPL GOOG GOOGL PANW
Exposures Legal Product Safety
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost
Via Stocktwits
Tickers OMER
Exposures Product Safety
Gilead’s Yeztugo HIV Shot Poised For Wider Reach After SCOTUS Ruling On Preventive Coverage: Wells Fargo
Via Stocktwits
Tickers GILD MS WFC
Exposures Product Safety
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers IOVA LLY NBIX NVO
Exposures Artificial Intelligence Interest Rates Product Safety
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Via MarketBeat
Tickers NKTR REGN SNY
Exposures Product Safety
Clark Smith, President of Golden Years Financial, Interviewed on The Influential Entrepreneurs Podcast Discussing Retirement Challenges
Via Get News
Topics Economy Product Recall Retirement
Exposures Interest Rates Legal Pension
Clark Smith, President of Golden Years Financial, Interviewed on The Influential Entrepreneurs Podcast Discussing Retirement Challenges
Via Authority Press Wire
Topics Economy Product Recall Retirement
Exposures Interest Rates Legal Pension
FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
Via Benzinga
Tickers BMY
Exposures Product Safety
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
Via Investor Brand Network
Topics Economy Intellectual Property
Tickers NRXP
Exposures Intellectual Property Product Safety Supply Chain
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half
Via NewMediaWire
Topics Death
Tickers ICU
Exposures Death Product Safety
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half
Via TheNewswire.com
Topics Death
Tickers ICU
Exposures Death Product Safety
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
Via NewMediaWire
Tickers ICU
Exposures Product Safety
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
Via TheNewswire.com
Tickers ICU
Exposures Product Safety
Surrogacy4All Releases 2025 Rankings of Top Surrogacy Agencies, Championing Transparency, and Ethical Care for Intended Parents
Via Get News
Exposures Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Class Action: Levi &amp; Korsinsky Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
5 Revealing Analyst Questions From Royalty Pharma’s Q1 Earnings Call
Via StockStory
Topics Earnings World Trade
Exposures Financial Product Safety Tariff
Experts Examine How Insurance May Adapt to Psychedelic-Assisted Therapy
Via Press Release Distribution Service
Tickers CI
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.